Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Manufacturing rationalisation

1 Apr 2009 07:00

RNS Number : 8292P
Xaar PLC
01 April 2009
 



FOR IMMEDIATE RELEASE

1 April 2009

Xaar plc

RATIONALISATION OF MANUFACTURING FACILITIES

100 NEW HIGH TECHNOLOGY JOBS TO BE CREATED IN THE UK

Xaar plc ("Xaar" or "the Company"), the inkjet printing technology group headquartered in Cambridge, can confirm that it will now proceed with the rationalisation of its manufacturing facilities.

As part of the proposed rationalisation, approximately 100 new jobs will be created at the Company's 'state of the art' Huntingdon plant over the period of the transfer.

Further to the disclosure of the proposal in the final results announcement on 23 March 2009, the period of consultation with the representatives of the workforce of approximately 130 at the Company's Swedish manufacturing facility in Järfälla, near Stockholm, has now ended. Accordingly, Xaar's Board has decided to proceed with rationalising its production of printheads by transferring manufacturing from the plant in Sweden to its facility in Huntingdon, near Cambridge, and the eventual closure of the Järfälla facility. The process is expected to take about two years to complete in a phased transfer to ensure minimal disruption to the business and continued availability of finished product.

As stated previously, the transfer is expected to achieve:

a substantial reduction in manufacturing costs;
a reduction in management overhead;
better use of production capacity;
improved operational efficiency; and 
the elimination of exchange rate exposure between Sterling and the Swedish Krona.

Ian Dinwoodie, Xaar's Chief Executive, commented:

"We plan to fund the relocation of our Swedish manufacturing activities to Huntingdon with a mix of cash generated from our operations and some external equipment finance. We aim to preserve our cash balances and strong balance sheet."

Ends

 

CONTACTS

Xaar plc:
01223-423663
Ian Dinwoodie, Chief Executive
www.xaar.com
Andrew Taylor, Finance Director
 
 
 
Bankside Consultants:
 
Steve Liebmann or Simon Bloomfield
020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMGGFFFMLGLZM
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.